dobutamine has been researched along with indomethacin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Goto, M; Griffin, A | 1 |
| Baughman, KL; Feldman, AM; Gerstenblith, G; Kaufman, KD; Levine, MA | 1 |
| Goto, M; Griffin, AJ | 1 |
| Clemmons, RM; Huston, LY; Meyers, KM | 1 |
| Kübler, W; Niroomand, F; Tiefenbacher, CP; Tillmanns, H; Zimmermann, R | 1 |
| Brousseau, D; Desjardins, JF; Dumont, L; Jasmin, G | 1 |
1 review(s) available for dobutamine and indomethacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for dobutamine and indomethacin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Adjuvant effects of beta-adrenergic drugs on indomethacin treatment of newborn canine endotoxic shock.
Topics: Adjuvants, Pharmaceutic; Animals; Animals, Newborn; Dobutamine; Dogs; Dopamine; Drug Therapy, Combination; Escherichia coli; Hemodynamics; Indomethacin; Lipopolysaccharides; Shock, Septic | 1991 |
Negative inotropic effects of furosemide in the isolated rabbit heart: a prostaglandin-mediated event.
Topics: Adenylyl Cyclases; Animals; Calcium; Colforsin; Coronary Circulation; Cyclic AMP; Depression, Chemical; Dobutamine; Furosemide; Heart; In Vitro Techniques; Indomethacin; Male; Myocardial Contraction; Myocardium; Prostaglandins; Rabbits | 1987 |
Adjuvant effects of beta-adrenergic drugs in the indomethacin treatment of highly lethal endotoxic shock.
Topics: Animals; Dobutamine; Dopamine; Drug Synergism; Drug Therapy, Combination; Indomethacin; Isoproterenol; Male; Rats; Rats, Inbred Strains; Shock, Septic | 1988 |
Regulation of canine platelet function II. Catecholamines.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acids; Blood Platelets; Clonidine; Dobutamine; Dogs; Drug Synergism; Epinephrine; Female; Indomethacin; Isoproterenol; Kinetics; Male; Phenylephrine; Platelet Aggregation | 1983 |
Adaptation of myocardial blood flow to increased metabolic demand is not dependent on endothelial vasodilators in the rat heart.
Topics: Acetylcholine; Adaptation, Physiological; Adrenergic beta-1 Receptor Agonists; Animals; Coronary Circulation; Cyclooxygenase Inhibitors; Dobutamine; Female; Glyburide; Indomethacin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Perfusion; Potassium Channels; Rats; Rats, Wistar; Regional Blood Flow; Vasodilator Agents | 1997 |
Altered coronary and cardiac adrenergic response in the failing hamster heart: role of cyclooxygenase derivatives.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Animals; Coronary Circulation; Cricetinae; Cyclooxygenase Inhibitors; Dobutamine; Heart Diseases; In Vitro Techniques; Indomethacin; Mesocricetus; Myocardial Contraction; Phenylephrine; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Terbutaline; Vasodilation | 2002 |